Abstract:In a recent study by Wang et al.,1 the Chang liver cell line (American Type Culture Collection No. CCL-13) was used as a hepatocellular carcinoma cell line with low invasive potential. The authors reported that RN181 was highly expressed in the Chang cell line, moderately expressed in the HepG2 cell line, and weakly expressed in the SMMC-7721 cell line, then concluded that highly malignant tumor cells had a lower level of RN181. In recent years, the Chang cell line (American Type Culture Collection No. CCL-13) was widely used as a human normal hepatocyte model in various studies. Originally established in 1954,2 it was initially thought to be derived from normal liver tissue; however, based on isoenzyme analysis, HeLa marker chromosomes, and DNA fingerprinting, it was later found to have been established via HeLa cell contamination.3 We searched PubMed for "Chang cell line" for the past 3 years, and after reading the abstracts carefully, we found that there were 24, 15, and 20 publications in the years 2008, 2009, and 2010, respectively, in which the Chang cell line was used as a normal liver or liver cancer cell line. The misuse of this cell line appears to be relatively more frequent in works originating from emerging countries (South Korea [11/59], India [4/59], and China (19/59). However, five publications were also from the United States, suggesting that use of this HeLa contaminant without awareness of its true identity is a worldwide issue. In addition to the Chang cell line, recent studies have shown that 18%-36% of cell lines have been incorrectly designated,4, 5 and it is likely that false cell lines will continue to be established without the knowledge of their originators. Meanwhile, detecting false cell lines will be increasingly difficult as the number and varieties of circulating cell lines increase. Technically, the short tandem repeat analysis is an optimal candidate to authenticate a human cell line.5, 6 Although cell line authentication has been proposed as a condition for the research grant award and for the publication of research findings,7 resolution of the problem of misidentification and cross-contamination will require the collaboration of all involved parties: the users and originators of cell lines, cell banks, journals, and funding agencies. Qiang Gao M.D., Ph.D.*, Xiao-Ying Wang M.D., Ph.D.*, Jian Zhou M.D., Ph.D.* , Jia Fan M.D., Ph.D.* , * Liver Cancer Institute,Zhongshan Hospital and Shanghai Medical School, People's Republic of China, Cancer Center, Institute of Biomedical Sciences, Fudan University, Shanghai, People's Republic of China.

Identification of Cross Contamination of Human Cell Lines by STR Profiling

Advantages of a 21-loci short tandem repeat method for detection of cross-contamination in human cell lines

Evaluation of human embryonic stem cells and their differentiated fibroblastic progenies as cellular models for in vitro genotoxicity screening.

Human Biosample Authentication Using the High-Throughput, Cost-Effective SNPtraceTM System

Identification MRC-5 cell by using silver staining PCR product from STR system

A simple DNA extraction and rapid specific identification technique for single cells and early embryos of two breeds of Bos taurus.

Establishment of Cell Lines for Quality Control of Prenatal Genetic Diagnosis by SV40 LT Gene Transfection

Integrated DNA purification, PCR, sample cleanup, and capillary electrophoresis microchip for forensic human identification.

Cell Line Misidentification: the Case of the Chang Liver Cell Line

Misspellings or “miscellings”-non-verifiable cell lines in cancer research publications

In Reply to Torsvik Et Al. “spontaneous Transformation of Stem Cells in Vitro and the Issue of Cross-Contamination”

Application of the Isoenzyme Profile in the Development of Cell-Based Devices

Defining Microsatellite Alleles by Genotyping Global Indigenous Human Populations and Non-Human Primates.

Accurate profiling of forensic autosomal STRs using the Oxford Nanopore Technologies MinION device

Determination of mini-short tandem repeat (miniSTR) loci by using the combination of polymerase chain reaction (PCR) and microchip electrophoresis.

Using Cell Type-Specific Genes to Identify Cell-Type Transitions Between Different in vitro Culture Conditions

Individual identification from mixed-blood spots by using four cells with single-cell genomic analysis

A comparison of software for analysis of rare and common short tandem repeat (STR) variation using human genome sequences from clinical and population-based samples

Short Tandem Repeat Profiles in Ovarian Carcinoma Cells During Primary Culture

Tissue differences revealed by gene expression profiles of various cell lines.

Developmental Validation of the Microreader 23HS Plex ID System: A Novel Supplementary Non‐CODIS STR Multiplex Assay for Forensic Application